Financial News

Bristol Myers discloses $39 million in Russia exit costs

Reuters
Reuters
Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration

(Reuters) – Bristol Myers Squibb Co said on Wednesday it had transferred its commercial operations in Russia to a third-party distributor and incurred $39 million in related costs.

The drugmaker said in a filing that its remaining assets in the country were not material. (https://bit.ly/3PRxn5G)

(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

tagreuters.com2022binary_LYNXMPEI6Q0S2-BASEIMAGE

You appear to be using an ad blocker

Shore News Network is a free website that does not use paywalls or charge for access to original, breaking news content. In order to provide this free service, we rely on advertisements. Please support our journalism by disabling your ad blocker for this website.